Clinical Trial Update: A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

View source ↗

Summary

This study reviews the safety of diroximel fumarate (VUMERITY) in participants who took the drug during pregnancy and assesses health outcomes in their babies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• VUMERITY (diroximel fumarate)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: RECRUITING